In addition, APOE ε4 carriers had a 2% higher longitudinal PDSR (95% CI 0–3%, p = 0.045), which persisted after adjusting for CVD and diabetes, but was attenuated to 0% in Model 2 and to 1% after adjusting for diabetes (Model 5). This evidence concerns the gene APOE and diabetes mellitus.